May 08, 2025
Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website
Mar 03, 2025
Haemonetics Announces Executive Leadership Updates
Feb 24, 2025
Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference
Feb 06, 2025
Haemonetics 3rd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website
Jan 14, 2025
Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A
Jan 06, 2025
Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference
Dec 03, 2024
Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A
Nov 07, 2024
Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website
Oct 03, 2024
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024
Aug 15, 2024
Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System
Jul 30, 2024
Haemonetics Announces CE Mark Certification for the SavvyWire® Pre-Shaped Pressure Guidewire
Jul 08, 2024
Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2025 Results: August 8, 2024
May 23, 2024
Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes
May 21, 2024
Haemonetics Announces Proposed Convertible Senior Notes Offering
May 09, 2024
Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website
Apr 10, 2024
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
Apr 04, 2024
Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge
Apr 01, 2024
Haemonetics Corporation Completes Acquisition of Attune Medical
Mar 05, 2024
Haemonetics Announces Definitive Agreement to Acquire Attune Medical
Feb 21, 2024
Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference